Targeting cancer cell death with a bcl-x S adenovirus

Transformation is a complex cellular process that requires several genetic abnormalities. In many cases, one of these abnormalities is an inhibition of PCD, which provides a selective advantage for tumor cells. This has been recently shown in an in vivo model, where overexpression of Bcl-x L is a crucial step in the progression from hyperplasia to neoplasia and is accompanied by a significant decrease in tumor apoptosis [56].Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/46936/1/281_2004_Article_BF00787225.pd